首页 | 本学科首页   官方微博 | 高级检索  
     


Plasma glucosylceramides and cardiovascular risk in incident hemodialysis patients
Authors:Mark M. Mitsnefes  Jessica Fitzpatrick  Stephen M. Sozio  Bernard G. Jaar  Michelle M. Estrella  Jose M. Monroy-Trujillo  Wujuan Zhang  Kenneth Setchell  Rulan S. Parekh
Affiliation:1. Division of Nephrology and Hypertension, Cincinnati Children''s Hospital Medical Center, Cincinnati, OH, USA;2. Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada;3. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA;4. Welch Center for Prevention, Epidemiology, and Clinical Research, Baltimore, MD, USA;5. Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA;6. Nephrology Center of Maryland, Baltimore, MD, USA;7. Kidney Health Research Collaborative, Department of Medicine, University of California, San Francisco and Department of Medicine, San Francisco VA Medical Center, San Francisco, CA, USA;8. Division of Pathology, Cincinnati Children''s Hospital Medical Center, Cincinnati, Ohio, USA;9. Division of Nephrology, Department of Pediatrics and Medicine, The Hospital for Sick Children, University Health Network and University of Toronto, Ontario, Canada
Abstract:
Keywords:Sphingolipids  Cardiovascular disease  Atherosclerosis  Cardiomyopathy  Dialysis
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号